고속 액체 크로마토그래피(HPLC) 시장 보고서 : 제품, 용도, 지역별(2025-2033년)

The global high-performance liquid chromatography (HPLC) market size reached USD 5.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033.

High-performance liquid chromatography (HPLC) refers to the chromatographic technique of separating different compounds from a mixture. The technique uses a glass reservoir to hold the solution, numerous pumps to pass the pressurized liquid solvent containing the sample mixture, a column filled with a solid adsorbent material, fluorescence, mass-spectrometric, ultraviolet (UV)-spectroscopic and electrochemical detectors and data collection systems. It is commonly used for analytical chemistry and biochemistry to identify, quantify and purify individual components. As a result, the technique finds extensive applications for trace analysis, clinical diagnosis of diseases, quality control in food products and pharmaceutical drug development.

Significant growth in the pharmaceutical industry across the globe represents one of the key factors creating a positive outlook for the market. HPLC is widely used to analyze drug samples, quality control, manufacturing complex pharmaceutical drugs and obtaining faster and accurate compound separation results. Furthermore, the increasing demand for reliable HPLC systems for the purification of monoclonal antibodies is also driving the market growth. Various advancements in the column and pump technologies and the development of miniaturized, automated and computerized HPLC devices are acting as other growth-inducing factors. These advancements have assisted in conducting high-quality analysis that provides more accurate results in lesser time and enhances the overall convenience for the user. HPLC instrument manufacturers are also developing innovative column designs that can withstand high pressure from smaller, superficially porous particles, which is acting as another major growth-inducing factor. The emerging trend of biobanking and extensive research and development (R&D) activities in the field of life sciences are some of the other factors that are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Product:

• Instruments
  • HPLC System
• Automated
• Manual
  • Detectors
  • Pumps
  • Others
• Consumables
  • Columns
  • Tubes
  • Vials
  • Filters
  • Others
• Accessories

Breakup by Application:

• Clinical Research
• Diagnostics
• Forensic
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Gilson Inc., Hitachi Ltd., Perkinelmer Inc., Phenomenex Inc. (Danaher Corporation), Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation and Waters Corporation.

Key Questions Answered in This Report:

• How has the global high-performance liquid chromatography (HPLC) market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global high-performance liquid chromatography (HPLC) market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global high-performance liquid chromatography (HPLC) market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global High-performance Liquid Chromatography (HPLC) Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 HPLC System
      • 6.1.2.1.1 Automated
      • 6.1.2.1.2 Manual
    • 6.1.2.2 Detectors
    • 6.1.2.3 Pumps
    • 6.1.2.4 Others
  • 6.1.3 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Columns
    • 6.2.2.2 Tubes
    • 6.2.2.3 Vials
    • 6.2.2.4 Filters
    • 6.2.2.5 Others
  • 6.2.3 Market Forecast
• 6.3 Accessories
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Clinical Research
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Forensic
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Agilent Technologies Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Bio-RAD Laboratories Inc.
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Gilson Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Hitachi Ltd.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Perkinelmer Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Phenomenex Inc. (Danaher Corporation)
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Shimadzu Corporation
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Thermo Fisher Scientific Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Tosoh Corporation
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Waters Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis